Eli Lilly & Co.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 1.05B |
| FY2018 | 1.03B |
| FY2019 | 935.7M |
| FY2020 | 912.5M |
| FY2021 | 911.7M |
| FY2022 | 904.6M |
| FY2023 | 903.3M |
| FY2024 | 904.1M |
| FY2025 | 899.3M |
| FY2026 | 943.4M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 1.05B |
| FY2018 | 1.03B |
| FY2019 | 935.7M |
| FY2020 | 912.5M |
| FY2021 | 911.7M |
| FY2022 | 904.6M |
| FY2023 | 903.3M |
| FY2024 | 904.1M |
| FY2025 | 899.3M |
| FY2026 | 943.4M |